Clinical Trial

Evaluating the Efficacy and Safety of of HSK50042 in People With Idiopathic Pulmonary Fibrosis

Name: Evaluating the Efficacy and Safety of of HSK50042 in People With Idiopathic Pulmonary Fibrosis — clinical trial record (NCT07728721)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: IPF

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is open to adults with idiopathic pulmonary fibrosis who are at least 40 years old. The main objective is to evaluate of the efficacy and the secondary objective is to evaluate the safety and pharmacokinetic.

Trial Details

NCT Number	NCT07728721
Lead Sponsor	Haisco Pharmaceutical Group Co., Ltd.
Conditions	Idiopathic Pulmonary Fibrosis (IPF)
Enrollment	175 participants
Start Date	2026-08-25
Primary Completion	2028-04-10 (estimated)
Study Completion	2028-07-25 (estimated)
Updated on ClinicalTrials.gov	2026-07-27